Portfolio data

Browse all portfolio data news

    Latest portfolio data news

    Show news from

    Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022

    Freeline Reports Third Quarter 2022 Financial Results and Corporate Update

    Anaveon presents updated data from the Phase I/II study of ANV419 during the SITC Annual Meeting

    Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

    Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022

    New England Journal of Medicine Publishes Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a for People with Hemophilia B

    Load more

    Search